Esperion Therapeutics
$2.61
74
-$0.13-4.57% Today
Statistics
Day High
2.78
Day Low
2.59
52W High
4.18
52W Low
0.69
Volume
7,027,371
Avg. Volume
4,950,942
Mkt Cap
623.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MayExpected
Expected EPS
-0.023029
Actual EPS
N/A
Financials
-15.57%Profit Margin
Unprofitable664.63MRevenue
-103.49MNet Income
Analyst Ratings
$6.33Average Price Target
The highest estimate is 9.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ESPR. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Sanofi
SNY
Mkt Cap124.45B
Merck
MRK
Mkt Cap214.76B
Astrazeneca
AZN
Mkt Cap256.58B
Pfizer
PFE
Mkt Cap140.15B
Novartis
NVS
Mkt Cap237.61B
Abbvie
ABBV
Mkt Cap385.18B
GSK
GSK
Mkt Cap94.51B
Lilly(Eli) &
LLY
Mkt Cap772.28B
About
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Show more...
CEO
Mr. Sheldon L. Koenig M.B.A.
Employees
304
Country
US
ISIN
US29664W1053
Listings
0 Comments
Share your thoughts
FAQ
What is Esperion Therapeutics stock price today?▼
The current price of ESPR is $2.61 USD — it has decreased by -4.57% in the past 24 hours. Watch Esperion Therapeutics stock price performance more closely on the chart.
What is Esperion Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Esperion Therapeutics stocks are traded under the ticker ESPR.
Is Esperion Therapeutics stock price growing?▼
ESPR stock has fallen by -5.43% compared to the previous week, the month change is a -22.09% fall, over the last year Esperion Therapeutics has showed a +85.11% increase.
What is Esperion Therapeutics market cap?▼
Today Esperion Therapeutics has the market capitalization of 623.95M
When is the next Esperion Therapeutics earnings date?▼
Esperion Therapeutics is going to release the next earnings report on May 12, 2026.
What were Esperion Therapeutics earnings last quarter?▼
ESPR earnings for the last quarter are 0.22 USD per share, whereas the estimation was 0.24 USD resulting in a -9.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Esperion Therapeutics revenue for the last year?▼
Esperion Therapeutics revenue for the last year amounts to 664.63M USD.
What is Esperion Therapeutics net income for the last year?▼
ESPR net income for the last year is -103.49M USD.
How many employees does Esperion Therapeutics have?▼
As of April 01, 2026, the company has 304 employees.
In which sector is Esperion Therapeutics located?▼
Esperion Therapeutics operates in the Health Care sector.
When did Esperion Therapeutics complete a stock split?▼
The last stock split for Esperion Therapeutics was on June 11, 2013 with a ratio of 1:7.
Where is Esperion Therapeutics headquartered?▼
Esperion Therapeutics is headquartered in Ann Arbor, US.